Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The ubiquitin-proteasome system--micro target for macro intervention?

Joerg Herrmann1, Aaron Ciechanover, Lilach O Lerman

  • 1Division of Cardiovascular Diseases Mayo Clinic, Rochester, MN 55905, USA. herrmann.joerg@mayo.edu

International Journal of Cardiovascular Interventions
|July 16, 2005
PubMed
Summary

The ubiquitin-proteasome system degrades most intracellular proteins and is involved in inflammation and cell proliferation. Targeting this system offers potential for cardiovascular disease therapies, including atherosclerosis and restenosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The landscape of the ubiquitin-proteasome system in cancer.

Cell death and differentiation·2026
Same author

Sera from Phylogenetically Related Alligators, Crocodiles and Domestic Chickens Exhibit Comparable Anti-Cancer Activity.

Cells·2026
Same author

Precise Mapping of the Proteasome Interaction Region (PIR) of p62/SQSTM1: Decoupling Condensate Formation from Proteasome Recruitment.

Cells·2026
Same author

Proteasomal proteolysis in p62 condensates directs tumor suppression or growth depending on their subcellular localization.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Prevention of ubiquitination at K6 and K9 in mutant huntingtin exacerbates disease pathology in a knock-in mouse model.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Proteolysis targeting chimeric-based technology in myeloma and lymphoma.

Molecular cancer therapeutics·2026

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • The ubiquitin-proteasome system (UPS) is crucial for intracellular protein degradation, regulating 80-90% of cellular proteins.
  • The UPS plays a significant role in biological processes like inflammation and cell proliferation.
  • Atherosclerosis and restenosis are cardiovascular diseases significantly influenced by inflammation and cell proliferation.

Purpose of the Study:

  • To review the ubiquitin-proteasome system's role in cardiovascular diseases.
  • To explore the potential of targeting the UPS in cardiovascular therapy.

Main Methods:

  • Literature review of the ubiquitin-proteasome system.
  • Analysis of existing data on UPS involvement in cardiovascular pathology.

Related Experiment Videos

  • Discussion of proteasome inhibitors and drug-eluting stents.

    • Main Results:

    • The UPS is implicated in key pathways relevant to cardiovascular diseases.
    • Proteasome inhibitors represent a promising therapeutic avenue.
    • Drug-eluting stents offer a potential localized delivery method for these inhibitors.

    Conclusions:

    • The ubiquitin-proteasome system is a viable therapeutic target for cardiovascular diseases.
    • Targeted inhibition of proteasomes may offer novel treatment strategies for atherosclerosis and restenosis.